Evolution-guided design of super-restrictor antiviral proteins reveals a breadth-versus-specificity tradeoff
Posted on: 13 March 2019
Preprint posted on 22 February 2019
Article now published in PLOS Biology at http://dx.doi.org/10.1371/journal.pbio.3000181
Using evolution to guide protein engineering – Revealing trade-offs in antiviral activity of MxA
Selected by Connor RosenCategories: evolutionary biology, immunology, microbiology
Background:
Mammalian cells encode a wide variety of antiviral proteins that exploit various mechanisms to impair viral infection. A single host species (for example, humans) must contend with a range of viral pathogens, providing a strong evolutionary pressure on immune proteins to maintain activity in the face of rapidly evolving viral substrates. This “evolutionary arms race” drives the rapid evolution of sequences at key interaction sites in viral and immune proteins, as viruses mutate to avoid immune restriction and immune proteins evolve to regain restrictive capacity. These key interaction sites can therefore be identified by computational analysis of substitution rates among orthologues of an immune gene. If the substitution rate of nucleotides that results in amino acid changes is higher than synonymous (amino-acid preserving) substitutions, the site is under “positive selection”, while those where synonymous changes are more frequent are under “negative” or “purifying” selection. Previous work had identified sites of positive selection in the antiviral protein MxA, and substitutions at one of these sites explained species differences in viral restrictive capacity of different MxA orthologues [Mitchell and Patzina 2012]. Here, Colón-Thillet et al use deeper combinatorial mutagenesis studies to further characterize the roles of positively selected sites in MxA antiviral activity.
Key Findings:
- Most combinations of substitutions impair MxA activity, but a few have “super-restrictor” activity
The authors use a combinatorial mutagenesis approach to screen multiple simultaneous substitutions in the L4 loop of MxA, rather than individual amino acid substitutions. Using a cell-based assay for replication of Thogoto virus (THOV), they showed that the vast majority (95%) of variants had reduced THOV restriction activity. This is consistent with the suggestion from positive selection that these sites are important for antiviral activity, and so many mutations should reduce activity. Nonetheless, several amino acid combinations had increased restriction activity relative to the already extremely potent wild-type MxA – the authors call these “super-restrictors”.
- Super-restrictors are dependent on epistatic interactions between different residues
The few super-restrictors found in the initial screen all shared an aromatic amino acid at position 561, but aromatic variants at 561 were not always sufficient in other combinations to enhance activity. This suggested that other residues may contribute to enhanced activity. Indeed, by fixing position 561 and re-varying the other positions, the authors identified further super-restrictors. However, no individual substitution tested was sufficient to enhance activity to the extent of the combinatorial super-restrictors. In fact, some (the authors explore the WT-enhancing 540A substitution as an example) could decrease the activity of super-restrictors, despite enhanced activity in isolation. This demonstrated that equally potent super-restrictors would be unlikely to be discovered by testing single substitutions and combining favorable results from those simpler screens.
- Increased specificity of super-restrictors suggests a breadth-vs-specificity tradeoff in MxA evolution
MxA restricts many viruses beyond THOV. The authors tested whether super-restrictor activity towards THOV would result in similarly increased activity against another virus, Influenza A (IAV). While some variants that had impaired THOV restriction were still capable of restricting IAV, none of the super-restrictors showed IAV restriction activity as potent as wild-type. Thus, there is a tradeoff between the ability of MxA to potently neutralize one virus and its breadth to serve as a “multi-tasking” antiviral protein. It seems likely that MxA is under evolutionary pressure to maintain breadth, rather than specializing to target individual viruses.
Importance:
This preprint illustrates the balance of evolutionary pressures acting on a key antiviral protein, MxA. By demonstrating the combinatorial activity of multiple positively selected sites for determining potency of MxA, the authors show how evolution-guided design may give even deeper insights into the ongoing arms race between the immune systems and pathogens. The breadth-specificity tradeoff identified suggests the importance of a broad antiviral repertoire and reveals how evolution has maximized the response to the varying pressures acting on the host immune system at MxA. This may serve as a broader paradigm for understanding the constraints on evolution of antiviral immunity in general.
Moving Forward / Questions for Authors
- Many interesting extensions of this approach to studying epistatic interactions and combinatorial effects of antiviral immunity might rely on more high-throughput approaches. For example, use of a fluorescent reporter for antiviral activity instead of luciferase would enable FACS-based selections that could expand throughput to enable screening of all possible L4 amino acid combinations (3.2 million total). Orthogonal reporters for different viruses (e.g. GFP for THOV and RFP for IAV) would enable exploration of the overall shape of the breadth-specificity tradeoff curve. However, not all assays are readily amenable to scale-up of this nature. It will be exciting to see if this viral restriction activity assay may be expanded to enable larger scale examination of activity.
- In some examples of protein evolution, an ancient “epistatic ratchet” constrains subsequent evolution [Bridgham 2009]. Is it possible that the sites available for positive selection have been “set” by an ancient evolutionary epistatic ratchet? For example, what are the relationships between MxA L4 residues and the positively selected loop in MxB and their respective “evolvabilities” for viral specificity and breadth? What about in other antiviral families, such as the TRIM or APOBEC families? One may imagine that members of a family have different breadth-specificity tradeoffs due to ancient epistatic sites that now no longer show as positively selected.
- Super-restrictors show decreased breadth against distinct viruses. Does this tradeoff hold for variants of a single virus? For example, is the minimal set of mutations in THOV to evade MxA restriction different for super-restrictors compared to wtMxA?
References:
- Mitchell P.S., Patzina C. et al. Evolution-Guided Identification of Antiviral Specificity Determinants in the Broadly Acting Interferon-Induced Innate Immunity Factor MxA. Cell Host Microbe 12(4) 598-604
- Cridgham J.T. et al. An epistatic ratchet constrains the direction of glucocorticoid receptor evolution. Nature 461(7263) 515-519
doi: https://doi.org/10.1242/prelights.9402
Read preprintSign up to customise the site to your preferences and to receive alerts
Register hereAlso in the evolutionary biology category:
Geometric analysis of airway trees shows that lung anatomy evolved to enable explosive ventilation and prevent barotrauma in cetaceans
Sarah Young-Veenstra
Enhancer-driven cell type comparison reveals similarities between the mammalian and bird pallium
Rodrigo Senovilla-Ganzo
Modular control of time and space during vertebrate axis segmentation
AND
Natural genetic variation quantitatively regulates heart rate and dimension
Girish Kale, Jennifer Ann Black
Also in the immunology category:
Alzheimer’s Disease Patient Brain Extracts Induce Multiple Pathologies in Vascularized Neuroimmune Organoids for Disease Modeling and Drug Discovery
Manuel Lessi
Global coordination of protrusive forces in migrating immune cells
yohalie kalukula
Integrin conformation-dependent neutrophil slowing obstructs the capillaries of the pre-metastatic lung in a model of breast cancer
Simon Cleary
Also in the microbiology category:
Green synthesized silver nanoparticles from Moringa: Potential for preventative treatment of SARS-CoV-2 contaminated water
Safieh Shah, Benjamin Dominik Maier
Intracellular diffusion in the cytoplasm increases with cell size in fission yeast
Leeba Ann Chacko, Sameer Thukral
Significantly reduced, but balanced, rates of mitochondrial fission and fusion are sufficient to maintain the integrity of yeast mitochondrial DNA
Leeba Ann Chacko
preListsevolutionary biology category:
in the‘In preprints’ from Development 2022-2023
A list of the preprints featured in Development's 'In preprints' articles between 2022-2023
List by | Alex Eve, Katherine Brown |
preLights peer support – preprints of interest
This is a preprint repository to organise the preprints and preLights covered through the 'preLights peer support' initiative.
List by | preLights peer support |
EMBO | EMBL Symposium: The organism and its environment
This preList contains preprints discussed during the 'EMBO | EMBL Symposium: The organism and its environment', organised at EMBL Heidelberg, Germany (May 2023).
List by | Girish Kale |
9th International Symposium on the Biology of Vertebrate Sex Determination
This preList contains preprints discussed during the 9th International Symposium on the Biology of Vertebrate Sex Determination. This conference was held in Kona, Hawaii from April 17th to 21st 2023.
List by | Martin Estermann |
EMBL Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture (2021)
A list of preprints mentioned at the #EESmorphoG virtual meeting in 2021.
List by | Alex Eve |
Planar Cell Polarity – PCP
This preList contains preprints about the latest findings on Planar Cell Polarity (PCP) in various model organisms at the molecular, cellular and tissue levels.
List by | Ana Dorrego-Rivas |
TAGC 2020
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
List by | Maiko Kitaoka et al. |
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
List by | Hiral Shah |
COVID-19 / SARS-CoV-2 preprints
List of important preprints dealing with the ongoing coronavirus outbreak. See http://covidpreprints.com for additional resources and timeline, and https://connect.biorxiv.org/relate/content/181 for full list of bioRxiv and medRxiv preprints on this topic
List by | Dey Lab, Zhang-He Goh |
1
SDB 78th Annual Meeting 2019
A curation of the preprints presented at the SDB meeting in Boston, July 26-30 2019. The preList will be updated throughout the duration of the meeting.
List by | Alex Eve |
Pattern formation during development
The aim of this preList is to integrate results about the mechanisms that govern patterning during development, from genes implicated in the processes to theoritical models of pattern formation in nature.
List by | Alexa Sadier |
Also in the immunology category:
Journal of Cell Science meeting ‘Imaging Cell Dynamics’
This preList highlights the preprints discussed at the JCS meeting 'Imaging Cell Dynamics'. The meeting was held from 14 - 17 May 2023 in Lisbon, Portugal and was organised by Erika Holzbaur, Jennifer Lippincott-Schwartz, Rob Parton and Michael Way.
List by | Helen Zenner |
Fibroblasts
The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!
List by | Osvaldo Contreras |
Single Cell Biology 2020
A list of preprints mentioned at the Wellcome Genome Campus Single Cell Biology 2020 meeting.
List by | Alex Eve |
Autophagy
Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.
List by | Sandra Malmgren Hill |
Antimicrobials: Discovery, clinical use, and development of resistance
Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.
List by | Zhang-He Goh |
Zebrafish immunology
A compilation of cutting-edge research that uses the zebrafish as a model system to elucidate novel immunological mechanisms in health and disease.
List by | Shikha Nayar |
Also in the microbiology category:
BioMalPar XVI: Biology and Pathology of the Malaria Parasite
[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria
List by | Dey Lab, Samantha Seah |
1
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
List by | Hiral Shah |
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
List by | Dey Lab |
Antimicrobials: Discovery, clinical use, and development of resistance
Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.
List by | Zhang-He Goh |